Studylog has been featured in such publications as the following:

Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models

M. Pia Morelli, John J. Tentler, Gillian N. Kulikowski, etc. Clin Cancer Res. 2012 Feb 15; 18(4): 10.1158/1078-0432.CCR-11-1507.

Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer

John J. Tentler, Sujatha Nallapareddy, Aik Choon Tan, etc. Mol Cancer Ther. 2010 Dec; 9(12): 3351–3362.

RLIP76: A Target for Kidney Cancer Therapy

Sharad S. Singhal, Jyotsana Singhal, Sushma Yadav, etc. Cancer Res. 2009 May 15; 69(10): 4244–4251.

Development of flexible-heteroarotinoids for kidney cancer

Tongzu Liu,1, Chioniso Patience Masamha, Shylet Chengedza, etc. Mol Cancer Ther. 2009 May; 8(5): 1227–1238.


Regression of prostate cancer xenografts by RLIP76 depletion

Sharad S. Singhal, Cherice Roth, Kathryn Leake, etc. Biochem Pharmacol. 2009 Mar 15; 77(6): 1074–1083.

Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts

Robert J. Kinders, Melinda Hollingshead, Sonny Khin, etc. Clin Cancer Res. 2008 Nov 1; 14(21): 6877–6885.